Brandes Investment Partners, LP Taro Pharmaceutical Industries LTD Transaction History

Brandes Investment Partners, LP

$8.37 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$40.97 - $43.33 $7.86 Million - $8.31 Million	-191,824 Reduced 40.32%	283,917 $12 Million
Q4 2023 Feb 09, 2024	BUY	$32.77 - $42.31 $106,600 - $137,634	3,253 Added 0.69%	475,741 $19.9 Million
Q3 2023 Nov 13, 2023	SELL	$35.46 - $40.13 $14,574 - $16,493	-411 Reduced 0.09%	472,488 $17.8 Million
Q2 2023 Aug 11, 2023	BUY	$24.24 - $40.97 $255,562 - $431,946	10,543 Added 2.28%	472,899 $17.9 Million
Q1 2023 May 10, 2023	BUY	$23.0 - $31.59 $1.12 Million - $1.54 Million	48,811 Added 11.8%	462,356 $11.2 Million
Q4 2022 Feb 13, 2023	SELL	$27.6 - $32.99 $194,221 - $232,150	-7,037 Reduced 1.67%	413,545 $12 Million
Q3 2022 Nov 14, 2022	BUY	$28.74 - $39.9 $132,002 - $183,260	4,593 Added 1.1%	420,582 $12.6 Million
Q2 2022 Aug 12, 2022	BUY	$35.0 - $43.59 $1.28 Million - $1.6 Million	36,667 Added 9.67%	415,989 $15 Million
Q1 2022 May 10, 2022	BUY	$43.12 - $50.3 $1.28 Million - $1.49 Million	29,606 Added 8.47%	379,322 $16.4 Million
Q4 2021 Feb 11, 2022	BUY	$47.6 - $65.0 $3.96 Million - $5.41 Million	83,156 Added 31.2%	349,716 $17.5 Million
Q3 2021 Nov 12, 2021	BUY	$62.34 - $73.38 $760,548 - $895,236	12,200 Added 4.8%	266,560 $17 Million
Q2 2021 Aug 11, 2021	SELL	$70.26 - $76.64 $10.6 Million - $11.6 Million	-151,114 Reduced 37.27%	254,360 $18.3 Million
Q1 2021 May 14, 2021	SELL	$70.48 - $79.95 $474,753 - $538,543	-6,736 Reduced 1.63%	405,474 $30.3 Million
Q4 2020 Feb 11, 2021	BUY	$54.4 - $73.42 $3.83 Million - $5.17 Million	70,444 Added 20.61%	412,210 $29.8 Million
Q3 2020 Nov 12, 2020	BUY	$54.41 - $68.2 $915,393 - $1.15 Million	16,824 Added 5.18%	341,766 $18.7 Million
Q2 2020 Aug 12, 2020	BUY	$61.66 - $70.16 $4.21 Million - $4.79 Million	68,287 Added 26.61%	324,942 $21.6 Million
Q1 2020 May 13, 2020	BUY	$59.35 - $88.73 $10.5 Million - $15.7 Million	176,713 Added 221.05%	256,655 $15.7 Million
Q4 2019 Feb 13, 2020	BUY	$74.18 - $97.92 $1.85 Million - $2.44 Million	24,877 Added 45.18%	79,942 $7.03 Million
Q3 2019 Nov 13, 2019	SELL	$75.36 - $86.57 $63,302 - $72,718	-840 Reduced 1.5%	55,065 $5.47 Million
Q2 2019 Aug 13, 2019	SELL	$83.92 - $108.88 $785,407 - $1.02 Million	-9,359 Reduced 14.34%	55,905 $6.26 Million
Q1 2019 May 10, 2019	SELL	$85.97 - $108.09 $279,660 - $351,616	-3,253 Reduced 4.75%	65,264 $9.27 Million
Q4 2018 Feb 11, 2019	BUY	$78.25 - $107.92 $1.85 Million - $2.55 Million	23,666 Added 52.77%	68,517 $7.94 Million
Q3 2018 Nov 09, 2018	BUY	$97.82 - $116.09 $90,972 - $107,963	930 Added 2.12%	44,851 $6.59 Million
Q2 2018 Aug 13, 2018	SELL	$97.62 - $120.59 $1.57 Million - $1.95 Million	-16,133 Reduced 26.86%	43,921 $7.64 Million
Q1 2018 May 15, 2018	SELL	$95.91 - $107.26 $1.07 Million - $1.19 Million	-11,109 Reduced 15.61%	60,054 $5.93 Million
Q4 2017 Feb 12, 2018	BUY	$104.5 - $126.38 $5.15 Million - $6.23 Million	49,327 Added 225.9%	71,163 $7.45 Million
Q3 2017 Nov 13, 2017	BUY	$97.26 - $116.2 $2.12 Million - $2.54 Million	21,836	21,836 $2.46 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.

Account